Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2695 |
|
| Actual shortage: | 246 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2440 (91%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195557 |
| TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2024-01-25 | 2024-02-08 | 217237 |
| TEVA-CANDESARTAN | 32MG | TABLET | Actual shortage | 2024-03-28 | 2024-06-07 | 223853 |
| TEVA-TECNAL | 330MG 40MG 50MG | CAPSULE | Resolved | 2022-02-10 | 2022-07-01 | 154714 |
| TEVA-TECNAL | 330MG 40MG 50MG | TABLET | Resolved | 2022-04-21 | 2024-01-19 | 159189 |
| TEVA-TECNAL | 330MG 40MG 50MG | CAPSULE | Resolved | 2022-07-25 | 2022-10-18 | 165459 |
| TEVA-TECNAL | 330MG 40MG 50MG | TABLET | Resolved | 2023-06-20 | 2023-07-06 | 195850 |
| TEVA-TECNAL | 330MG 40MG 50MG | CAPSULE | Actual shortage | 2024-04-05 | 2024-05-16 | 224448 |
| TEVA-TECNAL C 1/4 | 330MG 50MG 15MG 40MG | CAPSULE | Resolved | 2019-11-14 | 2020-02-07 | 98741 |
| TEVA-TECNAL C 1/4 | 330MG 50MG 15MG 40MG | CAPSULE | Resolved | 2020-03-12 | 2020-07-09 | 108620 |
| TEVA-TECNAL C 1/2 | 330MG 50MG 30MG 40MG | CAPSULE | Resolved | 2019-10-31 | 2020-02-07 | 97608 |
| TEVA-TECNAL C 1/2 | 330MG 50MG 30MG 40MG | CAPSULE | Resolved | 2020-03-06 | 2020-03-26 | 107973 |
| TEVA-TECNAL | 330MG 50MG 40MG | CAPSULE | Resolved | 2017-03-17 | 2018-02-22 | 3151 |
| TEVA-TECNAL | 330MG 50MG 40MG | TABLET | Resolved | 2019-06-13 | 2019-07-15 | 86620 |
| TEVA-TECNAL | 330MG 50MG 40MG | CAPSULE | Resolved | 2019-08-29 | 2020-07-10 | 92657 |
| TEVA-RISEDRONATE | 35MG | TABLET | Resolved | 2018-03-16 | 2018-07-30 | 43138 |
| TEVA-RISEDRONATE | 35MG | TABLET | Resolved | 2020-02-07 | 2020-04-09 | 105561 |
| TEVA-RISEDRONATE | 35MG | TABLET | Resolved | 2020-04-03 | 2020-04-09 | 110776 |
| TEVA-RISEDRONATE | 35MG | TABLET | Resolved | 2022-06-03 | 2024-02-06 | 161973 |
| ACT DILTIAZEM T | 360MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2017-03-17 | 2018-10-11 | 3362 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 |